• Explore /
  • Poster
  • / A molecular and clinico-pathological model for predicting abiraterone acetate/prednisone (AA/P) efficacy in metastatic castrate resistant prostate cancer (mCRPC).

A molecular and clinico-pathological model for predicting abiraterone acetate/prednisone (AA/P) efficacy in metastatic castrate resistant prostate cancer (mCRPC).

Abstract Poster

Authors

Manish Kohli

Manish Kohli

Mayo Clinic, Rochester, MN, Rochester, MN

Manish Kohli , Rui Qin , Liguo Wang , Hugues Sicotte , Rachel Carlson , Winston Tan , Rafael E. Jimenez , Liewei Wang , Jeanette Eckel-Passow , Brian Addis Costello , Henry C. Pitot , Fernando Quevedo , Roxana Stefania Dronca , Kevin Wu , Timothy Jerome Moynihan , Thai Huu Ho , Alan Haruo Bryce , Thomas D Atwell , Brendan P McMenomy , Scott Dehm

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Prostate) Cancer

Track

Genitourinary Cancer

Sub Track

Prostate Cancer

Clinical Trial Registration Number

NCT# 01953640

Citation

J Clin Oncol 33, 2015 (suppl; abstr 5056)

DOI

10.1200/jco.2015.33.15_suppl.5056

Abstract #

5056

Poster Bd #

50

Abstract Disclosures

Similar Posters

First Author: Ignacio Gil-Bazo

First Author: Daniel J. George

First Author: Morgan Goujon

First Author: Adam Kessel